Project results scheduled for 2019

Deliverables Contents Lead organisation
D1.2 Report providing a checklist to assess the methodological quality of model-based economic evaluations of personalised medicine iMTA
D6.1 Plan for the Data Management throughout the project AIT

Project results scheduled for 2020

Deliverables Contents Lead organisation
D1.1 Report with guidance on health economic modelling of personalised medicine iMTA
D2.1 Report on the thematic outcomes of a workshop dealing with enhanced health/pharmaco-economic models for personalised medicine SYREON
D4.1 Report on the major findings from the expert and stakeholder interviews with regard to benefits and challenges of personalised medicine for the European Social Models of Health Care AIT
D5.1   Technical report on the outcome of the workshop dealing with enhanced health/pharmaco-economic models for personalised medicine DLR

Project results scheduled for 2021

Deliverables Contents Lead organisation
D2.2 Cost-effectiveness models for three case studies SYREON
D2.3 Budget impact models for three case studies SYREON
D2.4 Report with recommendation on the refinement of the guidance developed D1.1 SYREON
D2.5 Developed Models populated with input data from three EU Member States SYREON
D3.1 Report on a set of appropriate financing and payment models for personalised medicine for different types of health care systems in EU UOXF
D3.2 Report with action plan for the adoption of appropriate financing and payment models for personalised medicine across the EU UOXF
D4.2 Report on “The Benefits & Challenges of Personalised Medicine for the European Social Models of Health Care” with scenarios for personalised medicine futures, enhancing personalised medicine networks for health benefits, institutional support for personalised medicine and the significance of personalised medicine for the citizen AIT
D5.2 Technical report on the workshop on financing and payment models in the context of personalised medicine DLR
D5.3 Technical report on the outcomes of the Stakeholder Conference on “How can health/pharmaco-economic models along with financing and payment models support the sustainable implementation of personalised medicine in our health systems?” DLR